查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
抗体发现市场规模和预测、全球和区域份额、趋势和成长机会分析报告范围：按抗体类型、性质、服务、最终用户和地理位置
市场调查报告书
商品编码
1463827

抗体发现市场规模和预测、全球和区域份额、趋势和成长机会分析报告范围：按抗体类型、性质、服务、最终用户和地理位置

Antibody Discovery Market Size and Forecasts, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Antibody Type, Nature, Service, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 180 Pages | 订单完成后即时交付

价格

抗体发现市场规模预计将从 2022 年的 29.4 亿美元激增至 2030 年的 49.2 亿美元；预计 2022 年至 2030 年市场复合年增长率为 6.7%。研发投资的增加和癌症发生率的上升推动了抗体发现市场的成长。

以生物製品为重点的生物製药行业的扩张导致对抗体研究服务的需求比以前更高。产业参与者和学术机构之间加强合作促进资源共享并加速抗体发现。向以患者为中心的药物开发的转变，强调个人化医疗和患者偏好，推动了抗体发现市场的发展。

高通量筛选、噬菌体展示和下一代定序等持续的技术进步提高了抗体发现过程的效率和速度。政府组织和私人企业对研发活动的资助增加也刺激了抗体发现计画。单株抗体由于其针对特定抗原的特异性和有效性而在治疗应用中越来越受欢迎，导致对抗体研究服务的需求增加。因此，对抗体疗法的需求不断增长以及对外包的偏好可能会对未来几年的抗体发现市场预测产生重大影响。

癌症发生率上升推动抗体发现市场

根据全球癌症观察站 (GLOBOCAN) 2020 年发布的估计，全球有 1,930 万癌症病例。美国、中国和印度的病例数明显较高。 GLOBOCAN 进一步资料，到 2040 年，印度的癌症病例将达到约 208 万例，较 2020 年增加 57.5%。全世界的癌症。根据美国癌症协会的报告，自 2019 年 1 月以来，约有 1,690 万有癌症史的人居住在美国。化。肺癌、乳癌、大肠癌、摄护腺癌和乳癌是最常见的癌症类型。癌症发生率的上升引起了全世界的关注。以下是 2020 年全球报告的常见癌症病例清单。

  • 表 1. 2020 年全球新癌症病例

Sr. No.癌症类型 病例数（百万）

1胃1.09

2皮肤（非黑色素瘤）1.2

3前列腺1.41

4结肠和直肠1.93

5肺2.21

6乳房2.26

资料来源：世界卫生组织，2020 年 2 月

癌症现在是一种生活方式疾病，常见于饮食习惯不健康和缺乏体能活动的人。经常饮酒和吸烟会增加患这种疾病的风险。低收入和中等收入国家的慢性传染病可进一步加剧癌症危险因子。癌症发生率的激增表明需要创新的癌症治疗方法。单株抗体是一类有前景的标靶抗癌药物，可增强免疫系统抑制癌细胞活性和消除癌细胞的天然能力。抗体药物偶联物（ADC）在癌症治疗中也显示出有希望的结果。此外，现代生物技术的进步使研究人员和公司能够提供精心设计的新型抗体，为成功治疗各种类型的癌症铺平道路。因此，不同类型癌症发生率的迅速上升促进了抗体发现市场的成长。

市场趋势

客製化抗体的开发

抗体是不可或缺的研究工具，使各个科学领域的研究人员能够指定、识别、定位和量化其蛋白质标靶。医疗技术的进步为更快、更有效率地发现根据客户要求量身定制的抗体提供了支持。将生物资讯整合到抗体的发现中引发了客製化抗体研究的进步。人工智慧 (AI) 有潜力成为客製化抗体发现过程中必不可少的增值工具。 AI 和机器学习 (ML) 演算法分析大型资料集、预测抗体-抗原交互作用并优化抗体特性。这些技术还可以帮助设计、筛选和先导化合物优化；识别模式；预测结合亲和力；并对候选抗体进行优先排序以进行进一步表征。除了有效分析和解释大规模抗体筛选资料的需求之外，巨量资料分析解决方案的可用性不断增加和运算能力的进步也推动了人工智慧和机器学习的使用。人工智慧和机器学习技术的整合有可能提高抗体发现计画的成功率，并促进更有效的治疗性抗体的开发。

客製化单株抗体的使用是肿瘤学研究中一个有吸引力的领域。大多数的临床试验是使用源自兔子的单株抗体进行。例如，抗VEGF，一种人源化抗血管生长内皮因子（兔单株抗体），目前正在进行临床研究，以评估其对转移性结直肠癌和其他实体肿瘤的作用。同样，抗 VEGF 药物正在临床研究中用于治疗老年黄斑部病变。兔源性单株抗体已被证明是比小鼠源性单株抗体更好的替代品，因为其抗原结合位点具有更大的互补决定区 (CDR)。此外，单株抗体可用于产生更高亲和力的克隆。例如，Creative Biolabs 提供各种客製化多克隆和单株抗体生产服务，从基因表现或胜肽合成到抗体纯化和标记。因此，在预测期内，客製化单株抗体很可能成为抗体发现市场的获利趋势。

「全球抗体发现市场」根据抗体类型、性质、服务、最终用户和地理位置进行细分。

基于抗体类型的见解

依产品类型，抗体发现市场分为单株抗体、多株抗体等。单株抗体细分市场将在 2022 年占据更大的市场份额。

单株抗体 (mAb) 旨在与患病细胞特异性相互作用，而不伤害健康细胞。癌症治疗是使用单株抗体的重要应用领域之一。这些是被广泛接受的生物製剂，预计在预测期内将为製药商带来高价值的机会。此外，患者和医生对单株抗体疗法应用的认识显着提高。因此，用于治疗各种适应症的重磅单株抗体的批准预计将有利于预测期内抗体发现市场的成长。 Avastin、Herceptin、Remicade、Rituxan 等多种药物已被 FDA 核准用于治疗癌症、类风湿性关节炎、克隆氏症、溃疡性结肠炎等。

基于最终用户的见解

根据最终用户，抗体发现市场分为製药和生技公司、研究实验室等。製药和生物技术公司细分市场在 2022 年占据最大的抗体发现市场份额，预计该细分市场在 2022 年至 2030 年期间的复合年增长率将达到 7.2%。

製药和生物技术公司在抗体发现过程中占据重要地位，因为它们有能力识别任何特定疾病的抗体并以商业规模生产它们。药物发现和开发对高特异性抗体的需求不断增加；蛋白质体学和基因组学领域的研究不断发展；对抗体辨识新标靶和检测方法的需求不断增加；癌症、爱滋病毒/爱滋病、免疫缺陷疾病和血液疾病等多个治疗领域不断增加的研发活动是推动製药和生物技术公司对抗体发现产品、解决方案和服务需求的关键因素。

美国食品药物管理局、疾病预防控制中心、全球癌症观测站、世界卫生组织、经济合作暨发展组织、厚生劳动省、食品药物安全部、生物医学高级研究与开发权威机构（BARDA）正在准备抗体发现市场研究报告时所引用的一些相关来源。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解
  • 抗体发现市场（按地理位置）

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：抗体发现市场格局

  • 概述
  • 全球PEST分析

第 5 章：抗体发现市场 - 主要市场动态

  • 抗体发现市场 - 主要市场动态
  • 市场驱动因素
    • 增加研发投资
    • 癌症发生率上升
  • 市场限制
    • 生产成本高
  • 市场机会
    • 发展中地区生物技术产业的扩散
  • 未来的趋势
    • 客製化抗体的开发
  • 驱动因素和限制的影响：

第 6 章：抗体发现市场 - 全球市场分析

  • 抗体发现市场收入，2022-2030
  • 抗体发现市场 - 按地理位置细分，2022-2030 年

第 7 章：抗体发现市场分析 - 依抗体类型

  • 概述
  • 单株抗体
  • 多株抗体抗体
  • 其他的

第 8 章：抗体发现市场分析 - 本质上

  • 概述
  • 人性化与人性化
  • 嵌合体
  • 鼠类

第 9 章：抗体发现市场分析 - 按服务

  • 概述
  • 噬菌体展示
  • 杂交瘤
  • 基因改造动物
  • 酵母展示
  • 单细胞

第 10 章：抗体发现市场分析 - 按最终用户

  • 概述
  • 製药和生物技术公司
  • 研究实验室
  • 其他的

第 11 章：抗体发现市场 - 地理分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 12 章：抗体发现市场-产业格局

  • 概述
  • 抗体发现市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 13 章：公司简介

  • Charles River Laboratories International Inc
  • Creative Biolabs Inc
  • Evotec SE
  • Bruker Cellular Analysis Inc
  • BioDuro LLC
  • Sartorius AG
  • Aragen Life Sciences Ltd
  • Twist Bioscience Corp
  • NanoCellect Biomedical Inc
  • Biocytogen Pharmaceuticals Beijing Co Ltd

第 14 章：附录

Product Code: TIPRE00007411

The antibody discovery market size is projected to surge from US$ 2.94 billion in 2022 to US$ 4.92 billion by 2030; the market is estimated to record a CAGR of 6.7% during 2022-2030. The increasing investments in research & development and the rising incidence of cancer propel the antibody discovery market growth.

The expansion of biopharmaceutical industry, which is highly focused on biologics, results in a higher demand for antibody research services than before. Increased collaborations between industry players and academic institutions facilitate resource sharing and accelerated antibody discovery. The shift toward patient-centered drug development, emphasizing personalized medicine and patient preferences, boosts the antibody discovery market.

Continued technological advancements such as high-throughput screening, phage display, and next-generation sequencing have resulted in improved efficiency and speed of antibody discovery processes. Increased funding for research and development activities from government organizations and private companies also spurs antibody discovery initiatives. Monoclonal antibodies are gaining popularity in therapeutic applications due to their specificity and effectiveness in targeting specific antigens, resulting in increased demand for antibody research services. Therefore, the growing demand for antibody-based therapies and the preference for outsourcing are likely to have a significant impact on the antibody discovery market forecast in the next few years.

Rising Incidence of Cancer Drives the Antibody Discovery Market

As per the Global Cancer Observatory (GLOBOCAN) estimates published in 2020, there were 19.3 million cancer cases across the world. The number of cases was significantly high in the US, China, and India. The GLOBOCAN further estimates that cancer cases in India would reach ~2.08 million by 2040, representing a rise of 57.5% from 2020. Similarly, as per the World Health Organization (WHO) data published in February 2022, ~10 million people have died from cancer worldwide. As per a report by the American Cancer Society, ~16.9 million individuals with a history of cancer have been residing in the US since January 2019. By January 2030, the population of cancer survivors is estimated to reach 22.1 million, which can be primarily associated with the aging of the population. Lung, breast, colorectal, prostate, and breast are among the most commonly reported cancer types. The rising incidences of cancer have raised concerns worldwide. Below is the list of common cancer cases reported worldwide in 2020.

  • Table 1.New Cancer Cases Worldwide, in 2020

Sr. No.Cancer TypeNumber of Cases (Million)

1Stomach1.09

2Skin (non-melanoma)1.2

3Prostate1.41

4Colon and rectum1.93

5Lung2.21

6Breast2.26

Source: World Health Organization, February 2020

Cancer is now a lifestyle disease commonly seen among people with unhealthy eating habits and those who don't engage much in physical activities. The frequent consumption of alcohol and tobacco adds to the risk of developing this condition. Chronic infectious diseases in low- and middle-income countries can further aggravate the cancer risk factors. An upsurge in the incidence of cancer indicates the need for innovative cancer treatments. Monoclonal antibodies represent a promising class of targeted anticancer agents that enhance the natural ability of immune systems to suppress cancer cell activity and eliminate cancer cells. Antibody-drug conjugates (ADCs) have also shown promising results in cancer treatment. Further, progress in modern biotechnology allows researchers and companies to provide well-designed novel antibodies, paving the way for successful treatments of various types of cancer. Thus, the burgeoning incidence of different types of cancer boosts the antibody discovery market growth.

Market Trend

Developments for Custom Antibodies

Antibodies are indispensable research tools that enable researchers in various scientific fields to specify, identify, localize, and quantify their protein targets. Advancements in medical technologies provide support for faster and highly efficient discoveries of antibodies that are customized as per the customers' requirements. Integrating bioinformatics in the discovery of antibodies has triggered improvements in custom antibody research. Artificial intelligence (AI) has the potential to emerge as an essential, value addition tool in the discovery of custom antibodies. AI and machine learning (ML) algorithms analyze large data sets, predict antibody-antigen interactions, and optimize antibody properties. These techniques can also aid in design, screening, and lead optimization; identify patterns; predict binding affinities; and prioritize antibody candidates for further characterization. The use of AI and ML is driven by the growing availability of big data analytics solutions and advancements in computing power, in addition to the need to efficiently analyze and interpret large-scale antibody screening data. The integration of AI and ML technologies has the potential to improve the success rates of antibody discovery projects and facilitate the development of more effective therapeutic antibodies.

The use of custom monoclonal antibodies is an attractive area in oncology research. Most of the clinical trials are performed using monoclonal antibodies derived from rabbits. For instance, anti-VEGF, a humanized anti-vascular growth endothelial factor (rabbit mAb), is currently under clinical studies for the evaluation of its effects on metastatic colorectal cancer and other solid tumors. Likewise, anti-VEGF is under clinical studies to treat age-related macular degeneration. Monoclonal antibodies derived from rabbits are proven to be a superior alternative to mouse-derived monoclonal antibodies due to a larger complementarity-determining region (CDR) in the antigen-binding site. In addition, monoclonal antibodies can be used to produce higher affinity clones. For instance, Creative Biolabs offers various custom polyclonal and monoclonal antibody production services, from gene expression or peptide synthesis to antibody purification and labeling. Therefore, custom monoclonal antibodies are likely to emerge as a profitable trend in the antibody discovery market during the forecast period.

The "Global Antibody Discovery Market" is segmented on the basis of antibody type, nature, services, end user, and geography.

Antibody Type-Based Insights

Based on product type, the antibody discovery market is segmented into monoclonal antibodies, polyclonal antibodies, and others. The monoclonal antibodies segment held a larger market share in 2022. The same segment is anticipated to register a higher CAGR of 6.9% during the forecast period.

Monoclonal antibodies (mAbs) are designed to interact specifically with diseased cells without harming healthy cells. Cancer therapy is one of the significant application areas wherein monoclonal antibodies are used. These are widely accepted biologics and are expected to present high-value opportunities to pharmaceutical manufacturers during the forecast period. Moreover, awareness about the applications of mAb therapies is increasing notably among patients and physicians. As a result, the approval of blockbuster mAbs for the treatment of various indications is expected to favor the antibody discovery market growth during the forecast period. Several drugs such as Avastin, Herceptin, Remicade, and Rituxan have been approved by the FDA for cancer, rheumatoid arthritis, Crohn's disease, ulcerative colitis, etc.

End User-Based Insights

Based on end users, the antibody discovery market is segmented into pharmaceutical and biotechnology companies, research laboratories, and others. The pharmaceutical and biotechnology companies segment held the largest antibody discovery market share in 2022, and the same segment is anticipated to register a higher CAGR of 7.2% during 2022-2030.

Pharmaceutical and biotechnology companies account for a significant part of the antibody discovery process because of their capabilities to identify antibodies for any specific disease and produce them on commercial scales. The elevating demand for high-specificity antibodies for drug discovery and development; growing research in the areas of proteomics and genomics; increasing need for antibodies for identifying new targets and assays; and rising R&D activities in several therapeutic areas such as cancer, HIV/AIDS, immunodeficiency diseases, and blood disorders are the critical factors driving the demand for antibody discovery products, solutions, and services in pharmaceutical and biotechnology companies.

US Food and Drug Administration, Centers for Disease Control and Prevention, Global Cancer Observatory, World Health Organization, Organization for Economic Co-operation and Development, Ministry of Health, Labour and Welfare, Ministry of Food and Drug Safety, Biomedical Advanced Research and Development Authority (BARDA) are some of the relevant sources referred while preparing the antibody discovery market research report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Antibody Discovery Market, by Geography (US$ Million)

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Antibody Discovery Market Landscape

  • 4.1 Overview
  • 4.2 Global PEST Analysis

5. Antibody Discovery Market - Key Market Dynamics

  • 5.1 Antibody Discovery Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Investments in Research & Development
    • 5.2.2 Rising Incidence of Cancer
  • 5.3 Market Restraints
    • 5.3.1 High Cost of Production
  • 5.4 Market Opportunities
    • 5.4.1 Proliferation of Biotechnology Industry in Developing Regions
  • 5.5 Future Trends
    • 5.5.1 Developments for Custom Antibodies
  • 5.6 Impact of Drivers and Restraints:

6. Antibody Discovery Market - Global Market Analysis

  • 6.1 Antibody Discovery Market Revenue (US$ Million), 2022-2030
  • 6.2 Antibody Discovery Market- Breakdown by Geography, 2022-2030

7. Antibody Discovery Market Analysis - by Antibody Type

  • 7.1 Overview
  • 7.2 Monoclonal Antibodies
    • 7.2.1 Overview
    • 7.2.2 Monoclonal Antibodies: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Polyclonal Antibodies
    • 7.3.1 Overview
    • 7.3.2 Polyclonal Antibodies: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8. Antibody Discovery Market Analysis - by Nature

  • 8.1 Overview
  • 8.2 Human and Humanized
    • 8.2.1 Overview
    • 8.2.2 Human and Humanized: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Chimeric
    • 8.3.1 Overview
    • 8.3.2 Chimeric: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Murine
    • 8.4.1 Overview
    • 8.4.2 Murine: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

9. Antibody Discovery Market Analysis - by Services

  • 9.1 Overview
  • 9.2 Phage Display
    • 9.2.1 Overview
    • 9.2.2 Phage Display: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Hybridoma
    • 9.3.1 Overview
    • 9.3.2 Hybridoma: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Transgenic Animal
    • 9.4.1 Overview
    • 9.4.2 Transgenic Animal: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Yeast Display
    • 9.5.1 Overview
    • 9.5.2 Yeast Display: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Single Cell
    • 9.6.1 Overview
    • 9.6.2 Single Cell: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10. Antibody Discovery Market Analysis - by End User

  • 10.1 Overview
  • 10.2 Pharmaceutical and Biotechnology Companies
    • 10.2.1 Overview
    • 10.2.2 Pharmaceutical and Biotechnology Companies: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.3 Research Laboratories
    • 10.3.1 Overview
    • 10.3.2 Research Laboratories: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Others
    • 10.4.1 Overview
    • 10.4.2 Others: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

11. Antibody Discovery Market - Geographical Analysis

  • 11.1 North America Antibody Discovery Market, Revenue and Forecast To 2030
    • 11.1.1 Overview
    • 11.1.2 North America: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.1.2.1 North America: Antibody Discovery Market - Revenue and Forecast Analysis - by Antibody Type
      • 11.1.2.2 North America: Antibody Discovery Market - Revenue and Forecast Analysis - by Nature
      • 11.1.2.3 North America: Antibody Discovery Market - Revenue and Forecast Analysis - by Services
      • 11.1.2.4 North America: Antibody Discovery Market - Revenue and Forecast Analysis - by End User
    • 11.1.3 North America: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
      • 11.1.3.1 US
        • 11.1.3.1.1 Overview
        • 11.1.3.1.2 US: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.3.1.3 United States: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.1.3.1.4 United States: Antibody Discovery Market Breakdown, by Nature
        • 11.1.3.1.5 United States: Antibody Discovery Market Breakdown, by Services
        • 11.1.3.1.6 United States: Antibody Discovery Market Breakdown, by End User
      • 11.1.3.2 Canada
        • 11.1.3.2.1 Overview
        • 11.1.3.2.2 Canada: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.3.2.3 Canada: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.1.3.2.4 Canada: Antibody Discovery Market Breakdown, by Nature
        • 11.1.3.2.5 Canada: Antibody Discovery Market Breakdown, by Services
        • 11.1.3.2.6 Canada: Antibody Discovery Market Breakdown, by End User
      • 11.1.3.3 Mexico
        • 11.1.3.3.1 Overview
        • 11.1.3.3.2 Mexico: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.3.3.3 Mexico: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.1.3.3.4 Mexico: Antibody Discovery Market Breakdown, by Nature
        • 11.1.3.3.5 Mexico: Antibody Discovery Market Breakdown, by Services
        • 11.1.3.3.6 Mexico: Antibody Discovery Market Breakdown, by End User
  • 11.2 Europe Antibody Discovery Market, Revenue and Forecast To 2030
    • 11.2.1 Overview
    • 11.2.2 Europe: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.2.2.1 Europe: Antibody Discovery Market - Revenue and Forecast Analysis - by Antibody Type
      • 11.2.2.2 Europe: Antibody Discovery Market - Revenue and Forecast Analysis - by Nature
      • 11.2.2.3 Europe: Antibody Discovery Market - Revenue and Forecast Analysis - by Services
      • 11.2.2.4 Europe: Antibody Discovery Market - Revenue and Forecast Analysis - by End User
    • 11.2.3 Europe: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
      • 11.2.3.1 UK
        • 11.2.3.1.1 Overview
        • 11.2.3.1.2 UK: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.3.1.3 UK: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.2.3.1.4 UK: Antibody Discovery Market Breakdown, by Nature
        • 11.2.3.1.5 UK: Antibody Discovery Market Breakdown, by Services
        • 11.2.3.1.6 UK: Antibody Discovery Market Breakdown, by End User
      • 11.2.3.2 Germany
        • 11.2.3.2.1 Overview
        • 11.2.3.2.2 Germany: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.3.2.3 Germany: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.2.3.2.4 Germany: Antibody Discovery Market Breakdown, by Nature
        • 11.2.3.2.5 Germany: Antibody Discovery Market Breakdown, by Services
        • 11.2.3.2.6 Germany: Antibody Discovery Market Breakdown, by End User
      • 11.2.3.3 France
        • 11.2.3.3.1 Overview
        • 11.2.3.3.2 France: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.3.3.3 France: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.2.3.3.4 France: Antibody Discovery Market Breakdown, by Nature
        • 11.2.3.3.5 France: Antibody Discovery Market Breakdown, by Services
        • 11.2.3.3.6 France: Antibody Discovery Market Breakdown, by End User
      • 11.2.3.4 Italy
        • 11.2.3.4.1 Overview
        • 11.2.3.4.2 Italy: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.3.4.3 Italy: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.2.3.4.4 Italy: Antibody Discovery Market Breakdown, by Nature
        • 11.2.3.4.5 Italy: Antibody Discovery Market Breakdown, by Services
        • 11.2.3.4.6 Italy: Antibody Discovery Market Breakdown, by End User
      • 11.2.3.5 Spain
        • 11.2.3.5.1 Overview
        • 11.2.3.5.2 Spain: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.3.5.3 Spain: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.2.3.5.4 Spain: Antibody Discovery Market Breakdown, by Nature
        • 11.2.3.5.5 Spain: Antibody Discovery Market Breakdown, by Services
        • 11.2.3.5.6 Spain: Antibody Discovery Market Breakdown, by End User
      • 11.2.3.6 Rest of Europe
        • 11.2.3.6.1 Overview
        • 11.2.3.6.2 Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.3.6.3 Rest of Europe: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.2.3.6.4 Rest of Europe: Antibody Discovery Market Breakdown, by Nature
        • 11.2.3.6.5 Rest of Europe: Antibody Discovery Market Breakdown, by Services
        • 11.2.3.6.6 Rest of Europe: Antibody Discovery Market Breakdown, by End User
  • 11.3 Asia Pacific Antibody Discovery Market, Revenue and Forecast To 2030
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.3.2.1 Asia Pacific: Antibody Discovery Market - Revenue and Forecast Analysis - by Antibody Type
      • 11.3.2.2 Asia Pacific: Antibody Discovery Market - Revenue and Forecast Analysis - by Nature
      • 11.3.2.3 Asia Pacific: Antibody Discovery Market - Revenue and Forecast Analysis - by Services
      • 11.3.2.4 Asia Pacific: Antibody Discovery Market - Revenue and Forecast Analysis - by End User
    • 11.3.3 Asia Pacific: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
      • 11.3.3.1 China
        • 11.3.3.1.1 Overview
        • 11.3.3.1.2 China: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.1.3 China: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.3.3.1.4 China: Antibody Discovery Market Breakdown, by Nature
        • 11.3.3.1.5 China: Antibody Discovery Market Breakdown, by Services
        • 11.3.3.1.6 China: Antibody Discovery Market Breakdown, by End User
      • 11.3.3.2 Japan
        • 11.3.3.2.1 Overview
        • 11.3.3.2.2 Japan: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.2.3 Japan: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.3.3.2.4 Japan: Antibody Discovery Market Breakdown, by Nature
        • 11.3.3.2.5 Japan: Antibody Discovery Market Breakdown, by Services
        • 11.3.3.2.6 Japan: Antibody Discovery Market Breakdown, by End User
      • 11.3.3.3 India
        • 11.3.3.3.1 Overview
        • 11.3.3.3.2 India: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.3.3 India: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.3.3.3.4 India: Antibody Discovery Market Breakdown, by Nature
        • 11.3.3.3.5 India: Antibody Discovery Market Breakdown, by Services
        • 11.3.3.3.6 India: Antibody Discovery Market Breakdown, by End User
      • 11.3.3.4 Australia
        • 11.3.3.4.1 Overview
        • 11.3.3.4.2 Australia: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.4.3 Australia: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.3.3.4.4 Australia: Antibody Discovery Market Breakdown, by Nature
        • 11.3.3.4.5 Australia: Antibody Discovery Market Breakdown, by Services
        • 11.3.3.4.6 Australia: Antibody Discovery Market Breakdown, by End User
      • 11.3.3.5 South Korea
        • 11.3.3.5.1 Overview
        • 11.3.3.5.2 South Korea: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.5.3 South Korea: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.3.3.5.4 South Korea: Antibody Discovery Market Breakdown, by Nature
        • 11.3.3.5.5 South Korea: Antibody Discovery Market Breakdown, by Services
        • 11.3.3.5.6 South Korea: Antibody Discovery Market Breakdown, by End User
      • 11.3.3.6 Rest of APAC
        • 11.3.3.6.1 Overview
        • 11.3.3.6.2 Rest of APAC: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.6.3 Rest of APAC: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.3.3.6.4 Rest of APAC: Antibody Discovery Market Breakdown, by Nature
        • 11.3.3.6.5 Rest of APAC: Antibody Discovery Market Breakdown, by Services
        • 11.3.3.6.6 Rest of APAC: Antibody Discovery Market Breakdown, by End User
  • 11.4 Middle East & Africa Antibody Discovery Market, Revenue and Forecast To 2030
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.4.2.1 Middle East & Africa: Antibody Discovery Market - Revenue and Forecast Analysis - by Antibody Type
      • 11.4.2.2 Middle East & Africa: Antibody Discovery Market - Revenue and Forecast Analysis - by Nature
      • 11.4.2.3 Middle East & Africa: Antibody Discovery Market - Revenue and Forecast Analysis - by Services
      • 11.4.2.4 Middle East & Africa: Antibody Discovery Market - Revenue and Forecast Analysis - by End User
    • 11.4.3 Middle East & Africa: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
      • 11.4.3.1 Saudi Arabia
        • 11.4.3.1.1 Overview
        • 11.4.3.1.2 Saudi Arabia: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.1.3 Saudi Arabia: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.4.3.1.4 Saudi Arabia: Antibody Discovery Market Breakdown, by Nature
        • 11.4.3.1.5 Saudi Arabia: Antibody Discovery Market Breakdown, by Services
        • 11.4.3.1.6 Saudi Arabia: Antibody Discovery Market Breakdown, by End User
      • 11.4.3.2 South Africa
        • 11.4.3.2.1 Overview
        • 11.4.3.2.2 South Africa: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.2.3 South Africa: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.4.3.2.4 South Africa: Antibody Discovery Market Breakdown, by Nature
        • 11.4.3.2.5 South Africa: Antibody Discovery Market Breakdown, by Services
        • 11.4.3.2.6 South Africa: Antibody Discovery Market Breakdown, by End User
      • 11.4.3.3 UAE
        • 11.4.3.3.1 Overview
        • 11.4.3.3.2 UAE: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.3.3 UAE: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.4.3.3.4 UAE: Antibody Discovery Market Breakdown, by Nature
        • 11.4.3.3.5 UAE: Antibody Discovery Market Breakdown, by Services
        • 11.4.3.3.6 UAE: Antibody Discovery Market Breakdown, by End User
      • 11.4.3.4 Rest of Middle East & Africa
        • 11.4.3.4.1 Overview
        • 11.4.3.4.2 Rest of Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.4.3 Rest of Middle East & Africa: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.4.3.4.4 Rest of Middle East & Africa: Antibody Discovery Market Breakdown, by Nature
        • 11.4.3.4.5 Rest of Middle East & Africa: Antibody Discovery Market Breakdown, by Services
        • 11.4.3.4.6 Rest of Middle East & Africa: Antibody Discovery Market Breakdown, by End User
  • 11.5 South & Central America Antibody Discovery Market, Revenue and Forecast To 2030
    • 11.5.1 Overview
    • 11.5.2 South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.5.2.1 South & Central America: Antibody Discovery Market - Revenue and Forecast Analysis - by Antibody Type
      • 11.5.2.2 South & Central America: Antibody Discovery Market - Revenue and Forecast Analysis - by Nature
      • 11.5.2.3 South & Central America: Antibody Discovery Market - Revenue and Forecast Analysis - by Services
      • 11.5.2.4 South & Central America: Antibody Discovery Market - Revenue and Forecast Analysis - by End User
    • 11.5.3 South & Central America: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
      • 11.5.3.1 Brazil
        • 11.5.3.1.1 Overview
        • 11.5.3.1.2 Brazil: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.3.1.3 Brazil: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.5.3.1.4 Brazil: Antibody Discovery Market Breakdown, by Nature
        • 11.5.3.1.5 Brazil: Antibody Discovery Market Breakdown, by Services
        • 11.5.3.1.6 Brazil: Antibody Discovery Market Breakdown, by End User
      • 11.5.3.2 Argentina
        • 11.5.3.2.1 Overview
        • 11.5.3.2.2 Argentina: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.3.2.3 Argentina: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.5.3.2.4 Argentina: Antibody Discovery Market Breakdown, by Nature
        • 11.5.3.2.5 Argentina: Antibody Discovery Market Breakdown, by Services
        • 11.5.3.2.6 Argentina: Antibody Discovery Market Breakdown, by End User
      • 11.5.3.3 Rest of South & Central America
        • 11.5.3.3.1 Overview
        • 11.5.3.3.2 Rest of South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.3.3.3 Rest of South & Central America: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.5.3.3.4 Rest of South & Central America: Antibody Discovery Market Breakdown, by Nature
        • 11.5.3.3.5 Rest of South & Central America: Antibody Discovery Market Breakdown, by Services
        • 11.5.3.3.6 Rest of South & Central America: Antibody Discovery Market Breakdown, by End User

12. Antibody Discovery Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Antibody Discovery Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Charles River Laboratories International Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Creative Biolabs Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Evotec SE
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Bruker Cellular Analysis Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 BioDuro LLC
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Sartorius AG
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Aragen Life Sciences Ltd
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Twist Bioscience Corp
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 NanoCellect Biomedical Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Biocytogen Pharmaceuticals Beijing Co Ltd
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Antibody Discovery Market Segmentation
  • Table 2. New Cancer Cases Worldwide, in 2020
  • Table 3. North America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 4. North America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 5. North America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 6. North America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 7. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 8. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 9. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 10. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 11. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 12. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 13. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 14. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 15. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 16. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 17. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 18. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 19. Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 20. Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 21. Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 22. Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 23. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 24. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 25. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 26. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 27. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 28. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 29. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 30. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 31. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 32. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 33. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 34. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 35. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 36. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 37. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 38. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 39. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 40. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 41. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 42. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 43. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 44. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 45. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 46. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 47. Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 48. Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 49. Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 50. Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 51. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 52. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 53. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 54. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 55. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 56. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 57. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 58. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 59. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 60. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 61. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 62. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 63. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 64. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 65. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 66. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 67. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 68. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 69. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 70. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 71. Rest of APAC: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 72. Rest of APAC: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 73. Rest of APAC: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 74. Rest of APAC: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 75. Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 76. Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 77. Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 78. Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 79. Saudi Arabia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 80. Saudi Arabia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 81. Saudi Arabia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 82. Saudi Arabia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 83. South Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 84. South Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 85. South Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 86. South Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 87. UAE: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 88. UAE: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 89. UAE: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 90. UAE: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 91. Rest of Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 92. Rest of Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 93. Rest of Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 94. Rest of Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 95. South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 96. South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 97. South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 98. South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 99. Brazil: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 100. Brazil: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 101. Brazil: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 102. Brazil: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 103. Argentina: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 104. Argentina: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 105. Argentina: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 106. Argentina: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 107. Rest of South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 108. Rest of South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 109. Rest of South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 110. Rest of South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 111. Recent Inorganic Growth Strategies in the Antibody Discovery Market
  • Table 112. Recent Organic Growth Strategies in the Antibody Discovery Market
  • Table 113. Glossary of Terms, Antibody Discovery Market

List Of Figures

  • Figure 1. Antibody Discovery Market Segmentation, by Geography
  • Figure 2. Global - PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Antibody Discovery Market Revenue (US$ Million), 2022 - 2030
  • Figure 5. Antibody Discovery Market Breakdown by Geography, 2022 and 2030 (%)
  • Figure 6. Antibody Discovery Market Share (%) - by Antibody Type (2022 and 2030)
  • Figure 7. Monoclonal Antibodies: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Polyclonal Antibodies: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Others: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Antibody Discovery Market Share (%) - by Nature (2022 and 2030)
  • Figure 11. Human and Humanized: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Chimeric: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Murine: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Antibody Discovery Market Share (%) - by Services (2022 and 2030)
  • Figure 15. Phage Display: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Hybridoma: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Transgenic Animal: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Yeast Display: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Single Cell: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Antibody Discovery Market Share (%) - by End User (2022 and 2030)
  • Figure 21. Pharmaceutical and Biotechnology Companies: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Research Laboratories: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Others: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. North America: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 25. North America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 26. North America: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 27. US: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 28. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 29. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 30. Europe: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 31. Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 32. Europe: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 33. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 34. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 35. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 36. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 37. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 38. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 39. Asia Pacific: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 40. Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 41. Asia Pacific: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 42. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 43. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 44. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 45. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 46. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 47. Rest of APAC: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 48. Middle East & Africa: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 49. Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 50. Middle East & Africa: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 51. Saudi Arabia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 52. South Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 53. UAE: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 54. Rest of Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 55. South & Central America: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 56. South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 57. South & Central America: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 58. Brazil: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 59. Argentina: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 60. Rest of South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 61. Growth Strategies in the Antibody Discovery Market